Business
70% Of AI Jobs Located In These 3 Indian Cities: Naukri.com Report
Last Updated:
The highest demand for AI job openings is currently seen in engineering roles, including software and quality assurance, along with data science and analytics

Hyderabad accounts for 12.5% of AI jobs, followed by Pune at 9.6%, Chennai at 6.4% and Kolkata at 2.1%. (Representational Image)
Nearly 70% of artificial intelligence (AI)-related job openings listed on Naukri.com are concentrated in Bengaluru, Delhi-NCR and Mumbai, according to a report by property consultant CBRE. The findings are based on more than 64,500 active job listings on the portal as of December 2025.
Bengaluru has emerged as the leading centre for AI job hiring, accounting for 25.4% of job openings. Delhi-NCR follows closely with 24.8%, while Mumbai holds a 19.2% share. The analysis was based on active job postings specifically tagged with AI on Naukri.com. CBRE clarified that the data does not represent the entire AI job market in India, but indicates that the bulk of openings across sectors are concentrated in these three cities.
Among other cities, Hyderabad accounts for 12.5% of AI jobs, followed by Pune at 9.6%, Chennai at 6.4% and Kolkata at 2.1%.
The report noted that the highest demand for AI professionals is currently seen in engineering roles, including software and quality assurance, along with data science and analytics, and customer success, service and operations. These sectors are among the biggest adopters of AI-driven solutions.
CBRE Chairman and CEO Anshuman Magazine said AI is no longer just a subject of discussion but has become a key component of India’s broader economic and infrastructure growth story. He added that the growing demand for AI talent reflects more than a hiring trend, indicating that global companies increasingly view India not only as a service delivery base but as a hub for end-to-end innovation. This shift, he noted, is set to redefine India’s role in the global digital value chain.
The report attributes Bengaluru’s dominance in AI hiring to the strong presence of Global Capability Centres (GCCs). In 2025, the city accounted for more than one-third of the country’s total office space leasing by GCCs. Meanwhile, Delhi-NCR is witnessing rising demand for AI talent driven by sectors such as consulting, fintech, healthcare and public sector initiatives.
February 18, 2026, 20:56 IST
Read More
Business
FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals
Food and Drug Administration Commissioner Marty Makary warned that the U.S. is falling behind China in early-stage drug development and called for reforms that could streamline the process for starting trials on new treatments.
In an interview with CNBC on Wednesday, Makary specifically pointed to three bottlenecks that he said cause the U.S. to fall behind on those early drug trials.
These include hospital contracting as well as ethical reviews and approvals, both of which he called “clunky processes that take too long and are leaving us noncompetitive with the countries that are moving a lot faster.” He also pointed to the process for submitting and receiving approvals for Investigational New Drug, or IND, applications, which companies submit to test a product in humans.
“We walked into a mess,” Makary said, referring to how behind China the U.S. was in terms of Phase 1 clinical trials conducted in 2024.
Food and Drug Administration Commissioner Marty Makary speaks in the Oval Office at the White House on Jan. 29, 2026.
Samuel Corum | Getty Images
He said the FDA is “looking at everything,” such as whether it can partner with health systems and academic medical centers on the pre-IND process. That refers to when companies consult the FDA before formally filing an application.
Makary said the Trump administration should “partner with industry to help them deliver more cures and meaningful treatments for the American public because that is a common bipartisan goal that we all want. And we’re going to get it done in this administration.”
China’s biotech ecosystem has flourished over the last several years, driven by massive state investment, a vast talent pool and accelerated regulatory reforms. Once known for being a low-cost manufacturing base that pumps out copycats, China is rapidly evolving into a global innovation powerhouse.
Data from Global Data and Morgan Stanley shows that China now conducts more clinical trials than the U.S., accounts for nearly a third of new global drug approvals and is on pace to reach 35% of FDA approvals by 2040.
U.S. policymakers have been under pressure to take steps to boost innovation domestically.
Business
Mark Zuckerberg arrives to testify in social media addiction trial
In one such case, 29 state attorney generals are pushing a California federal court to demand that the platforms make a number of changes immediately, before any trial, including forcing Meta to remove all accounts known to belong to users under 13 years of age.
Business
India eyes diversification of crude oil sources; Piyush Goyal says would ‘love’ high-quality coking coal from US – The Times of India
India is looking to diversify its sources of crude oil, Commerce Minister Piyush Goyal has said. Goyal’s comments assume significance in light of the India-US trade deal joint statement which lowers tariffs on Indian exports to 18%. The Donald Trump administration has also removed the 25% penal tariffs on India on the condition that it stops buying crude oil from Russia.India’s crude imports from Russia have dropped since the US imposed sanctions on two major Russian oil firms in late 2025. According to reports, the share of Russian crude in India’s oil imports has dropped to the lowest level since late 2022 and analysts expect the numbers to drop further in the coming months.
India would ‘love’ high-quality coking coal from US
Piyush Goyal said India is looking to broaden its sourcing of crude oil and coking coal and would welcome supplies of premium-quality coking coal from the United States.Also Read | 18% tariffs, boost to exports, agriculture protected: How India benefits from trade deal with US? Explained“We want to diversify our oil sources. I want to diversify the source of coking coal for example. I am dependent on 2 or 3 geographies (for that) and prices keep fluctuating. I would love to have American coking coal which is high quality coming to India,” he said according to a PTI report.He noted that the US is well positioned to supply several products that are critical for India’s economic growth, including graphics processing units used in artificial intelligence, infrastructure and equipment for data centres, and high-performance computing systems.Goyal said India can produce goods in areas where US manufacturers may not be competitive, while America can serve as an important provider of technology and investment capital.Also Read | Trump removes 25% penal tariff: What happens if India stops buying Russian crude oil?He added that demand for aircraft from the US is already estimated at about $100 billion over the next five years, with additional capacity required to expand domestic aviation and help lower fares.Under the proposed interim trade pact with the United States, India has conveyed its intent to procure goods worth $500 billion from America over the next five years. An Indian delegation is scheduled to travel to the US next week to conclude the legal drafting of the agreement, which is expected to be signed in March.Piyush Goyal said entering into a trade agreement with the US would be beneficial for India, noting that it would create significant opportunities for domestic businesses, particularly in labour-intensive sectors and technology-driven services.Referring to India’s free trade agreements, Goyal noted that nine such pacts have been concluded over the past four years. He added that these deals were negotiated from a position of confidence, emphasising that India now engages in trade talks assertively, without defensiveness, and with a focus on long-term interests.
-
Business1 week agoAye Finance IPO Day 2: GMP Remains Zero; Apply Or Not? Check Price, GMP, Financials, Recommendations
-
Business1 week agoGold price today: How much 18K, 22K and 24K gold costs in Delhi, Mumbai & more – Check rates for your city – The Times of India
-
Fashion1 week agoComment: Tariffs, capacity and timing reshape sourcing decisions
-
Business6 days agoTop stocks to buy today: Stock recommendations for February 13, 2026 – check list – The Times of India
-
Fashion7 days agoIndia’s PDS Q3 revenue up 2% as margins remain under pressure
-
Politics6 days agoIndia clears proposal to buy French Rafale jets
-
Fashion1 week agoSaint Laurent retains top spot as hottest brand in Q4 2025 Lyst Index
-
Tech1 week agoRemoving barriers to tech careers
